Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of β-blockers market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of β-blockersmarket, defines the market attractiveness level of β-blockers market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of β-blockers industry, describes the types of β-blockers market, the applications of major players and the market size, and deeply analyzes the current situation of the global β-blockers market and the development prospects and opportunities of β-blockers industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global β-blockers market in Chapter 13.
By Player:
GSK
Astra Zeneca
Eli Lilly
Pfizer
Bayer
Teva Pharmaceutical
Bristol-Myers Squibb
Sanofi
Novartis
Merck
By Type:
Nonselective Agents
Selective Agents
By End-User:
Abnormal Heart Rhythms
Hypertension
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 β-blockers Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 β-blockers Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 β-blockers Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 β-blockers Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise β-blockers Market Analysis and Outlook to 2022
-
7.1 Global β-blockers Consumption (2017-2022)
-
7.2 United States β-blockers Consumption (2017-2022)
-
7.3 Europe β-blockers Consumption (2017-2022)
-
7.4 China β-blockers Consumption (2017-2022)
-
7.5 Japan β-blockers Consumption (2017-2022)
-
7.6 India β-blockers Consumption (2017-2022)
-
7.7 South Korea β-blockers Consumption (2017-2022)
8 Region and Country-wise β-blockers Market Analysis and Outlook to 2028
-
8.1 Global β-blockers Consumption Forecast (2022-2028)
-
8.2 United States β-blockers Consumption Forecast (2022-2028)
-
8.3 Europe β-blockers Consumption Forecast (2022-2028)
-
8.4 China β-blockers Consumption Forecast (2022-2028)
-
8.5 Japan β-blockers Consumption Forecast (2022-2028)
-
8.6 India β-blockers Consumption Forecast (2022-2028)
-
8.7 South Korea β-blockers Consumption Forecast (2022-2028)
9 Global β-blockers Market Outlook by Types and Applications to 2022
-
9.1 Global β-blockers Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nonselective Agents Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Selective Agents Consumption and Growth Rate (2017-2022)
-
9.2 Global β-blockers Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Abnormal Heart Rhythms Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hypertension Consumption and Growth Rate (2017-2022)
10 Global β-blockers Market Outlook by Types and Applications to 2028
-
10.1 Global β-blockers Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Nonselective Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Selective Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global β-blockers Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Abnormal Heart Rhythms Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
11 Global β-blockers Import and Export Analysis (Top 5 Countries)
-
11.1 Global β-blockers Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global β-blockers Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 β-blockers Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global β-blockers Market Competitive Analysis
-
14.1 GSK
-
14.1.1 GSK Company Details
-
14.1.2 GSK β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GSK β-blockers Product and Service
-
14.2 Astra Zeneca
-
14.2.1 Astra Zeneca Company Details
-
14.2.2 Astra Zeneca β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astra Zeneca β-blockers Product and Service
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Details
-
14.3.2 Eli Lilly β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly β-blockers Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer β-blockers Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer β-blockers Product and Service
-
14.6 Teva Pharmaceutical
-
14.6.1 Teva Pharmaceutical Company Details
-
14.6.2 Teva Pharmaceutical β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Teva Pharmaceutical β-blockers Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb β-blockers Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi β-blockers Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis β-blockers Product and Service
-
14.10 Merck
-
14.10.1 Merck Company Details
-
14.10.2 Merck β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck β-blockers Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of β-blockers
-
Figure β-blockers Picture
-
Table Global β-blockers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global β-blockers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global β-blockers Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global β-blockers Consumption by Country (2017-2022)
-
Figure United States β-blockers Consumption and Growth Rate (2017-2022)
-
Table Europe β-blockers Consumption and Growth Rate (2017-2022)
-
Figure China β-blockers Consumption and Growth Rate (2017-2022)
-
Figure Japan β-blockers Consumption and Growth Rate (2017-2022)
-
Figure India β-blockers Consumption and Growth Rate (2017-2022)
-
Figure South Korea β-blockers Consumption and Growth Rate (2017-2022)
-
Figure Global β-blockers Consumption Forecast by Country (2022-2028)
-
Figure United States β-blockers Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe β-blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure China β-blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan β-blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure India β-blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea β-blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonselective Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Abnormal Heart Rhythms Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Nonselective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Abnormal Heart Rhythms Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Table Global β-blockers Import by Region (Top 5 Countries) (2017-2028)
-
Table Global β-blockers Export by Region (Top 5 Countries) (2017-2028)
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK β-blockers Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca β-blockers Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly β-blockers Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer β-blockers Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer β-blockers Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical β-blockers Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb β-blockers Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi β-blockers Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis β-blockers Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck β-blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck β-blockers Product and Service
-
